IMCR SEC Filings: 8-K, 10-Q, S-3 & 424B – Immunocore

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 25, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Immunocore Reports Q3 2026 Financial Results and Business Updates

Nov 6, 2026

8-K

Immunocore Achieves Target Enrollment in Phase 3 TEBE-AM Trial for KIMMTRAK in Advanced Melanoma

Sep 14, 2026

8-K

Immunocore Reports Q2 2026 Financial Results and Business Update

Aug 6, 2026

8-K

Immunocore Holdings plc Announces Results of 2026 Annual General Meeting

May 27, 2026

8-K

Immunocore Reports Q1 2026 Financial Results and Business Update

May 6, 2026

8-K

Immunocore Reports Strong 2025 Financial Results Driven by KIMMTRAK Sales and Outlines Key 2026 Clinical Milestones

Feb 25, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B7

SHARE RESALE REGISTRATION | Shares amount: 1,584,014 | Share price: $94.70 | Conversion price: $94.70 | Offering amount: $150,000,000

Mar 17, 2025

424B7

SHARE RESALE REGISTRATION | Shares amount: 1,220,063

Apr 5, 2024

424B7

Form 424B7 - Prospectus [Rule 424(b)(7)]

Sep 30, 2022

424B5

ATM | Offering amount: $250,000,000

Sep 9, 2022

424B7

Form 424B7 - Prospectus [Rule 424(b)(7)]

May 5, 2022

424B4

9,935,896 American Depositary Shares-

Feb 8, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 8, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 7, 2025

POSASR

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Mar 17, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 20, 2024

S-3ASR

SHELF | ATM | Offering amount: $250,000,000.00

Mar 20, 2024

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 6, 2023

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

NEWPoint72 Asset Management, L.P. (Filed by)

Nov 9, 2026

SCHEDULE 13G/A

FMR LLC (Filed by)

Oct 7, 2026

SCHEDULE 13G/A

Vestal Point Capital, LP (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

WELLINGTON MANAGEMENT GROUP LLP (Filed by)

Aug 13, 2026

SCHEDULE 13G/A

FMR LLC (Filed by)

Aug 6, 2026

Ratcliffe Peter John (Reporting)

May 28, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 5, 2021

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 5, 2021

CORRESP

Form CORRESP - Correspondence

Feb 3, 2021

CORRESP

Form CORRESP - Correspondence

Feb 2, 2021

CORRESP

Form CORRESP - Correspondence

Feb 2, 2021

LETTER

Form UPLOAD - SEC-generated letter

Feb 2, 2021

Immunocore Holdings plc IMCR · SEC Filings